Saudi Medical Journal. 2007; 28 (5): 675-682
Dans Anglais
| IMEMR
| ID: emr-85097
ABSTRACT
In recent years, remarkable therapeutic advances have been made in the field of interventional cardiology with the introduction of statins, thienopyridines, such as clopidogrel and drug-eluting stents. Only a small minority in developing countries can afford these new treatment modalities, while the public health system would be rapidly bankrupted if it were to provide these modalities for all patients who might benefit from it. The purpose of this review article is to provide insight regarding the cost-effectiveness of these new treatment strategies and to address the added costs resulting upon their adoption and their appropriateness in developing countries
Recherche sur Google
Indice:
Méditerranée orientale
Sujet Principal:
Ticlopidine
/
Antiagrégants plaquettaires
/
Endoprothèses
/
Inhibiteurs de l'hydroxyméthylglutaryl-CoA réductase
/
Pays en voie de développement
Type d'étude:
Évaluation en économique de la santé
langue:
Anglais
Texte intégral:
Saudi Med. J.
Année:
2007
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS